B. Riley bridge promissory note extension
Company: Core Scientific
What the later record shows
Not a promise: a reported event · happened August 1, 2022
The claim reports that the amended and restated $60 million bridge note had already been entered into on August 1, 2022; the June 1, 2023 date is the note's maturity, not a promise. A later filing confirms the amendment and its terms.
“The Amended Bridge Notes amend the original notes having identical principal amounts to extend the maturity date from December 7, 2022 to June 1, 2023.”
2022-09-07 · Core Scientific 424B3 filed 2022-09-08 View cached copy (2026-09-13)Live source ↗
Checked October 10, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Core Scientific entered into an amended and restated bridge promissory note in principal amount of $60 million with B. Riley Commercial Capital, LLC, with maturity extended to June 1, 2023, bearing interest at 7% per annum
Source (primary)
Core Scientific 424B3 filed 2022-08-04 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “On August 1, 2022, Core Scientific, Inc. (the "Company") entered into two amended and restated bridge promissory notes, one in an aggregate principal amount of $60 million with B. Riley Commercial Capital, LLC ("B. Riley") and one in an aggregate principal amount of $15 million with an affiliate of B. Riley (the "Notes"). The Notes amend the original notes having identical principal amounts to extend the maturity date from December 7, 2022 to June 1, 2023. The Notes bear interest at a rate of 7% per annum”
How we checked this
Checked on October 11, 2026. The cited source supports every part of this claim.
The 8-K states that on August 1, 2022 Core Scientific entered into an amended and restated $60 million bridge note with B. Riley Commercial Capital, LLC, extending maturity to June 1, 2023 at 7% interest.
Confirmed in the source:
- Core Scientific entered into an amended and restated bridge promissory note
- The note's principal amount is $60 million
- The counterparty is B. Riley Commercial Capital, LLC
- The maturity was extended to June 1, 2023
- The note bears interest at 7% per annum
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522212620/d385020d424b3.htm) in full (13,514 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-08-04
Quote: “On August 1, 2022, Core Scientific, Inc. (the "Company") entered into two amended and restated bridge promissory notes, one in an aggregate principal amount of $60 million with B. Riley Commercial Capital, LLC ("B. Riley") and one in an aggregate principal amount of $15 million with an affiliate of B. Riley (the "Notes"). The Notes amend the original notes having identical principal amounts to extend the maturity date from December 7, 2022 to June 1, 2023. The Notes bear interest at a rate of 7% per annum”